LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,083,000 | +4.3% | 91,327 | 0.0% | 0.04% | -2.8% |
Q3 2020 | $8,706,000 | -16.2% | 91,327 | -1.6% | 0.04% | -20.0% |
Q2 2020 | $10,384,000 | +53.8% | 92,842 | 0.0% | 0.04% | +15.4% |
Q1 2020 | $6,751,000 | -30.3% | 92,842 | 0.0% | 0.04% | -11.4% |
Q4 2019 | $9,683,000 | +21.2% | 92,842 | +15.7% | 0.04% | +29.4% |
Q3 2019 | $7,990,000 | -10.9% | 80,274 | +2.1% | 0.03% | -20.9% |
Q2 2019 | $8,971,000 | +243.6% | 78,591 | +278.4% | 0.04% | +290.9% |
Q1 2019 | $2,611,000 | +32537.5% | 20,770 | +74078.6% | 0.01% | – |
Q3 2018 | $8,000 | -93.8% | 28 | -95.5% | 0.00% | -100.0% |
Q2 2018 | $129,000 | -84.4% | 626 | -87.5% | 0.00% | -75.0% |
Q1 2018 | $826,000 | +734.3% | 5,003 | +289.6% | 0.00% | – |
Q1 2015 | $99,000 | -47.3% | 1,284 | -67.9% | 0.00% | -100.0% |
Q3 2014 | $188,000 | – | 4,002 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |